Evidence map›Paper›PMID 35550307›Full record

ArticleArchivos de bronconeumologia2022

The Impact of Altitude on Mortality Rates From COVID-19 in Mexico.

David Martínez-Briseño, Rogelio Pérez-Padilla, Rosario Fernández-Plata, Manuel Castillejos-López, Anjarath Lorena Higuera-Iglesias

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Archivos de bronconeumologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Altitude and case fatality rate from COVID-19 during the pandemic in Peru, 2020-2022.Revista peruana de medicina experimental y salud publica · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David Martínez-BriseñoDepartment of Hospital Epidemiology and Infectology, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Tlalpan 4502, Mexico City 14080, Mexico.
Rogelio Pérez-PadillaDepartment of Research on Smoking and COPD, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Tlalpan 4502, Mexico City 14080, Mexico. Electronic address: perezpad@gmail.com.
Rosario Fernández-PlataDepartment of Hospital Epidemiology and Infectology, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Tlalpan 4502, Mexico City 14080, Mexico. Electronic address: rosferpla@gmail.com.
Manuel Castillejos-LópezDepartment of Hospital Epidemiology and Infectology, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Tlalpan 4502, Mexico City 14080, Mexico.
Anjarath Lorena Higuera-IglesiasDepartment of Hospital Epidemiology and Infectology, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Tlalpan 4502, Mexico City 14080, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AltitudeCOVID-19HumansMexico

Identifiers

PMID35550307
PMCPMC9026948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.